Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP870871.RA8Yop_0wO4iqbi40wty-1MjnWfTLaE_RRjGQ2cHOXGjg130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP870871.RA8Yop_0wO4iqbi40wty-1MjnWfTLaE_RRjGQ2cHOXGjg130_assertion type Assertion NP870871.RA8Yop_0wO4iqbi40wty-1MjnWfTLaE_RRjGQ2cHOXGjg130_head.
- NP870871.RA8Yop_0wO4iqbi40wty-1MjnWfTLaE_RRjGQ2cHOXGjg130_assertion description "[The results of this study on familial and unselected breast, ovarian, colorectal, and prostate cancer patients suggest that RAD51D is primarily a moderate penetrance susceptibility gene for ovarian cancer, with clinical significance for the carriers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP870871.RA8Yop_0wO4iqbi40wty-1MjnWfTLaE_RRjGQ2cHOXGjg130_provenance.
- NP870871.RA8Yop_0wO4iqbi40wty-1MjnWfTLaE_RRjGQ2cHOXGjg130_assertion evidence source_evidence_literature NP870871.RA8Yop_0wO4iqbi40wty-1MjnWfTLaE_RRjGQ2cHOXGjg130_provenance.
- NP870871.RA8Yop_0wO4iqbi40wty-1MjnWfTLaE_RRjGQ2cHOXGjg130_assertion SIO_000772 22652533 NP870871.RA8Yop_0wO4iqbi40wty-1MjnWfTLaE_RRjGQ2cHOXGjg130_provenance.
- NP870871.RA8Yop_0wO4iqbi40wty-1MjnWfTLaE_RRjGQ2cHOXGjg130_assertion wasDerivedFrom befree-20140225 NP870871.RA8Yop_0wO4iqbi40wty-1MjnWfTLaE_RRjGQ2cHOXGjg130_provenance.
- NP870871.RA8Yop_0wO4iqbi40wty-1MjnWfTLaE_RRjGQ2cHOXGjg130_assertion wasGeneratedBy ECO_0000203 NP870871.RA8Yop_0wO4iqbi40wty-1MjnWfTLaE_RRjGQ2cHOXGjg130_provenance.